First human clinical trial for nicotinamide riboside
Tuesday, October 11, 2016 - 04:31
in Health & Medicine
In the first controlled clinical trial of nicotinamide riboside (NR), a newly discovered form of Vitamin B3, researchers have shown that the compound is safe for humans and increases levels of a cell metabolite that is critical for cellular energy production and protection against stress and DNA damage.